Clinical Trial Update: Kineret in the Treatment of Rheumatoid Arthritis

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating Kineret (anakinra) for rheumatoid arthritis. The sponsor is Swedish Orphan Biovitrum (Sobi).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Rheumatoid Arthritis | Status: COMPLETED